Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-12,108
Closed -$533K 2546
2023
Q4
$533K Buy
12,108
+5,240
+76% +$207K ﹤0.01% 2306
2023
Q3
$216K Sell
6,868
-5,240
-43% -$205K ﹤0.01% 2507
2023
Q2
$1.02M Hold
12,108
﹤0.01% 1998
2023
Q1
$1.02M Sell
12,108
-1,671
-12% -$161K ﹤0.01% 1998
2022
Q4
$1.24M Hold
13,779
﹤0.01% 1750
2022
Q3
$1.37M Hold
13,779
﹤0.01% 1789
2022
Q2
$1.16M Sell
13,779
-481
-3% -$48.6K ﹤0.01% 1873
2022
Q1
$1.65M Buy
14,260
+67
+0.5% +$7.74K ﹤0.01% 1889
2021
Q4
$2.1M Sell
14,193
-1,877
-12% -$290K ﹤0.01% 1854
2021
Q3
$2.92M Buy
16,070
+2,291
+17% +$408K ﹤0.01% 1659
2021
Q2
$2.34M Buy
+13,779
New +$2.06M ﹤0.01% 1775
2021
Q1
Sell
-12,443
Closed -$1.72M 2610
2020
Q4
$1.72M Sell
12,443
-80
-0.6% -$9.92K ﹤0.01% 1743
2020
Q3
$1.16M Buy
12,523
+2,721
+28% +$235K ﹤0.01% 1778
2020
Q2
$773K Sell
9,802
-724
-7% -$49K ﹤0.01% 1912
2020
Q1
$578K Sell
10,526
-2,151
-17% -$133K ﹤0.01% 1918
2019
Q4
$750K Buy
12,677
+1,402
+12% +$85.6K ﹤0.01% 2064
2019
Q3
$670K Buy
11,275
+970
+9% +$55.3K ﹤0.01% 2143
2019
Q2
$591K Buy
10,305
+801
+8% +$51.9K ﹤0.01% 2139
2019
Q1
$633K Buy
9,504
+829
+10% +$54.3K ﹤0.01% 2011
2018
Q4
$521K Hold
8,675
﹤0.01% 1982
2018
Q3
$584K Hold
8,675
﹤0.01% 2019
2018
Q2
$681K Hold
8,675
﹤0.01% 1961
2018
Q1
$600K Buy
8,675
+5,100
+143% +$333K ﹤0.01% 1961
2017
Q4
$212K Buy
+3,575
New +$202K ﹤0.01% 2287
2016
Q4
Sell
-7,600
Closed -$370K 2594
2016
Q3
$370K Hold
7,600
﹤0.01% 2152
2016
Q2
$341K Hold
7,600
﹤0.01% 2165
2016
Q1
$388K Hold
7,600
﹤0.01% 2066
2015
Q4
$357K Hold
7,600
﹤0.01% 2252
2015
Q3
$331K Hold
7,600
﹤0.01% 2240
2015
Q2
$337K Buy
7,600
+1,600
+27% +$76K ﹤0.01% 2291
2015
Q1
$319K Buy
6,000
+200
+3% +$8.54K ﹤0.01% 2224
2014
Q4
$211K Hold
5,800
﹤0.01% 2447
2014
Q3
$281K Hold
5,800
﹤0.01% 2180
2014
Q2
$212K Buy
+5,800
New +$229K ﹤0.01% 2383

Other funds holding MODV

UBS AM's MODV Position: Q1 2024 in Review

UBS AM sold out of ModivCare (MODV) in Q1 2024, closing a stake of 12,108 shares — an estimated $533K sold.

UBS AM first reported a position in MODV in Q2 2014 and held it in 34 quarters. The position peaked at $2.92M in Q3 2021. 134 funds tracked by Wall St. Rank hold MODV as of Q1 2024.

  • UBS AM reported no remaining ModivCare position as of Q1 2024 after selling out during the quarter.
  • UBS AM sold 12,108 ModivCare shares in Q1 2024, an estimated $533K.
  • UBS AM first reported a position in ModivCare in Q2 2014 and held it in 34 quarters.
  • UBS AM's ModivCare position peaked at $2.92M in Q3 2021.
  • 134 funds tracked by Wall St. Rank held ModivCare as of Q1 2024.

Based on UBS AM's 13F filing for Q1 2024, filed 15 May 2024.